Kuraoka Masayuki, Snowden Pilar B, Nojima Takuya, Verkoczy Laurent, Haynes Barton F, Kitamura Daisuke, Kelsoe Garnett
Department of Immunology, Duke University, Durham, NC 27710, USA.
Human Vaccine Institute, Duke University, Durham, NC 27710, USA.
Cell Rep. 2017 Feb 14;18(7):1627-1635. doi: 10.1016/j.celrep.2017.01.050.
Activation-induced cytidine deaminase (AID) is required to purge autoreactive immature and transitional-1 (immature/T1) B cells at the first tolerance checkpoint, but how AID selectively removes self-reactive B cells is unclear. We now show that B cell antigen receptor (BCR) and endosomal Toll-like receptor (TLR) signals synergize to elicit high levels of AID expression in immature/T1 B cells. This synergy is restricted to ligands for endocytic TLR and requires phospholipase-D activation, endosomal acidification, and MyD88. The first checkpoint is significantly impaired in AID- or MyD88-deficient mice and in mice doubly heterozygous for AID and MyD88, suggesting interaction of these factors in central B cell tolerance. Moreover, administration of chloroquine, an inhibitor of endosomal acidification, results in a failure to remove autoreactive immature/T1 B cells in mice. We propose that a BCR/TLR pathway coordinately establishes central tolerance by hyper-activating AID in immature/T1 B cells that bind ligands for endosomal TLRs.
激活诱导的胞苷脱氨酶(AID)是在首个耐受检查点清除自身反应性未成熟和过渡1型(未成熟/T1)B细胞所必需的,但AID如何选择性清除自身反应性B细胞尚不清楚。我们现在发现,B细胞抗原受体(BCR)和内体Toll样受体(TLR)信号协同作用,在未成熟/T1 B细胞中引发高水平的AID表达。这种协同作用仅限于内吞性TLR的配体,并且需要磷脂酶-D激活、内体酸化和髓样分化因子88(MyD88)。在AID或MyD88缺陷小鼠以及AID和MyD88双杂合小鼠中,首个检查点受到显著损害,这表明这些因子在中枢B细胞耐受中相互作用。此外,给予内体酸化抑制剂氯喹会导致小鼠无法清除自身反应性未成熟/T1 B细胞。我们提出,BCR/TLR途径通过在结合内体TLR配体的未成熟/T1 B细胞中过度激活AID来协调建立中枢耐受。